Association between GSTP1 I105V polymorphisms and responses to GSTP1 inhibitor treatment: in silico and in vitro insights

References

• Altshuler, D., Brooks, L. D., Chakravarti, A., Collins, F. S., Daly, M. J., Donnelly, P., et al. (2005). A haplotype map of the human genome. Nature, 437(7063), 1299–1320.
   PubMed Web of Science ®Google Scholar
• Bansal, A., & Simon, M. C. (2018). Glutathione metabolism in cancer progression and treatment resistance. The Journal of Cell Biology, 217(7), 2291–2298. https://doi.org/10.1083/jcb.201804161
   PubMed Web of Science ®Google Scholar
• Bräutigam, M., Teusch, N., Schenk, T., Sheikh, M., Aricioglu, R. Z., Borowski, S. H., Neudörfl, J.-M., Baumann, U., Griesbeck, A. G., & Pietsch, M. (2015). Selective inhibitors of glutathione transferase P1 with trioxane structure as anticancer agents. ChemMedChem, 10(4), 629–639. https://doi.org/10.1002/cmdc.201402553
   PubMed Web of Science ®Google Scholar
• Buslaev, P., Gordeliy, V., Grudinin, S., & Gushchin, I. (2016). Principal component analysis of lipid molecule conformational changes in molecular dynamics simulations. Journal of Chemical Theory and Computation, 12(3), 1019–1028. https://doi.org/10.1021/acs.jctc.5b01106
   PubMed Web of Science ®Google Scholar
• Chatterjee, A., & Gupta, S. (2018). The multifaceted role of glutathione S-transferases in cancer. Cancer Letters, 433, 33–42. https://doi.org/10.1016/j.canlet.2018.06.028
   PubMed Web of Science ®Google Scholar
• Collins, F. S., Morgan, M., & Patrinos, A. (2003). The human genome project: Lessons from large-scale biology. Science (New York, N.Y.), 300(5617), 286–290. https://doi.org/10.1126/science.1084564
   PubMed Web of Science ®Google Scholar
• Cui, J., Li, G., Yin, J., Li, L., Tan, Y., Wei, H., Liu, B., Deng, L., Tang, J., Chen, Y., & Yi, L. (2020). GSTP1 and cancer: Expression, methylation, polymorphisms and signaling (Review). International Journal of Oncology, 56(4), 867–878. https://doi.org/10.3892/ijo.2020.4979
   PubMed Web of Science ®Google Scholar
• D'Annessa, I., Sattin, S., Tao, J., Pennati, M., Sànchez-Martìn, C., Moroni, E., Rasola, A., Zaffaroni, N., Agard, D. A., Bernardi, A., & Colombo, G. (2017). Design of allosteric stimulators of the Hsp90 ATPase as new anticancer leads. Chemistry (Weinheim an Der Bergstrasse, Germany), 23(22), 5188–5192. https://doi.org/10.1002/chem.201700169
   PubMed Web of Science ®Google Scholar
• Ertan-Bolelli, T., Bolelli, K., Musdal, Y., Yildiz, I., Aki-Yalcin, E., Mannervik, B., & Yalcin, I. (2018). Design and synthesis of 2-substituted-5-(4-trifluoromethylphenyl-sulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors. Artificial Cells, Nanomedicine, and Biotechnology, 46(3), 510–517. https://doi.org/10.1080/21691401.2017.1324464
   PubMed Web of Science ®Google Scholar
• Fulci, C., Rotili, D., De Luca, A., Stella, L., Morozzo Della Rocca, B., Forgione, M., Di Paolo, V., Mai, A., Falconi, M., Quintieri, L., & Caccuri, A. M. (2017). A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability. Journal of Enzyme Inhibition and Medicinal Chemistry, 32(1), 240–247. https://doi.org/10.1080/14756366.2016.1247059
   PubMed Web of Science ®Google Scholar
• Gide, T. N., Quek, C., Menzies, A. M., Tasker, A. T., Shang, P., Holst, J., Madore, J., Lim, S. Y., Velickovic, R., Wongchenko, M., Yan, Y., Lo, S., Carlino, M. S., Guminski, A., Saw, R. P. M., Pang, A., McGuire, H. M., Palendira, U., Thompson, J. F., … Wilmott, J. S. (2019). distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1/anti-CTLA-4 combined therapy. Cancer Cell, 35(2), 238–255.e6. +. https://doi.org/10.1016/j.ccell.2019.01.003
   PubMed Web of Science ®Google Scholar
• Hansson, J., Berhane, K., Castro, V. M., Jungnelius, U., & Mannervik, B. (1991). Sensitization of human-melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic-acid. Cancer Research, 51(1), 94–98.
   PubMed Web of Science ®Google Scholar
• Kim, S., & Misra, A. (2007). SNP genotyping: Technologies and biomedical applications. Annual Review of Biomedical Engineering, 9(1), 289–320. https://doi.org/10.1146/annurev.bioeng.9.060906.152037
   PubMedGoogle Scholar
• Kumar, S. U., & Doss, C. G. P. (2021). Computational investigation to identify potent inhibitors of the GTPase-Kirsten RAt sarcoma virus (K-Ras) mutants G12C and G12D. Computers in Biology and Medicine, 139, 104946. https://doi.org/10.1016/j.compbiomed.2021.104946
   PubMed Web of Science ®Google Scholar
• Kumar, S. U., Kamaraj, B., Varghese, R. P., Preethi, V. A., Bithia, R., & Doss, C. G. P. (2022). Mutations in G6PC2 gene with increased risk for development of type 2 diabetes: Understanding via computational approach. In R. Donev (Ed.), Protein design and structure (Vol 130, p. 351–373). Advances in Protein Chemistry and Structural Biology.
   Google Scholar
• Kumar, S. U., Sankar, S., Kumar, D. T., Younes, S., Younes, N., Siva, R., Doss, C. G. P., & Zayed, H. (2021). Molecular dynamics, residue network analysis, and cross-correlation matrix to characterize the deleterious missense mutations in GALE causing galactosemia III. Cell Biochemistry and Biophysics, 79(2), 201–219. https://doi.org/10.1007/s12013-020-00960-z
   PubMed Web of Science ®Google Scholar
• Lei, K., Gu, X., Alvarado, A. G., Du, Y., Luo, S., Ahn, E. H., Kang, S. S., Ji, B., Liu, X., Mao, H., Fu, H., Kornblum, H. I., Jin, L., Li, H., & Ye, K. (2020). Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma. Journal of Hematology & Oncology, 13(1), 141. https://doi.org/10.1186/s13045-020-00979-y
   PubMed Web of Science ®Google Scholar
• Lin, H., Sun, W., Zeng, T., Li, H., Xu, C., Chen, Y., & Yin, W. (2022). Identification of fosaprepitant as a novel GSTP1 inhibitor through structure-based virtual screening, molecular dynamics simulation, and biological evaluation. New Journal of Chemistry, 46(3), 1042–1053. https://doi.org/10.1039/D1NJ04597K
   Web of Science ®Google Scholar
• Lin, H., Wu, H., Li, H. D., Song, A. Q., & Yin, W. (2023). The essential role of GSTP1 I105V polymorphism in the prediction of CDNB metabolism and toxicity: In silico and in vitro insights. Toxicology in Vitro, 90, 105601. https://doi.org/10.1016/j.tiv.2023.105601
   PubMed Web of Science ®Google Scholar
• Liu, G., Wang, R., Wang, Y., Li, P., Zhao, G., Zhao, L., & Jing, Y. (2013). Ethacrynic acid oxadiazole analogs induce apoptosis in malignant hematologic cells through downregulation of Mcl-1 and c-FLIP, which was attenuated by GSTP1-1. Molecular Cancer Therapeutics, 12(9), 1837–1847. https://doi.org/10.1158/1535-7163.MCT-12-1224
   PubMed Web of Science ®Google Scholar
• Louie, S. M., Grossman, E. A., Crawford, L. A., Ding, L., Camarda, R., Huffman, T. R., Miyamoto, D. K., Goga, A., Weerapana, E., & Nomura, D. K. (2016). GSTP1 is a driver of triple-negative breast cancer cell metabolism and pathogenicity. Cell Chemical Biology, 23(5), 567–578. https://doi.org/10.1016/j.chembiol.2016.03.017
   PubMed Web of Science ®Google Scholar
• Luisi, G., Mollica, A., Carradori, S., Lenoci, A., De Luca, A., & Caccuri, A. M. (2016). Nitrobenzoxadiazole-based GSTP1-1 inhibitors containing the full peptidyl moiety of (pseudo) glutathione. Journal of Enzyme Inhibition and Medicinal Chemistry, 31(6), 924–930. https://doi.org/10.3109/14756366.2015.1070845
   PubMed Web of Science ®Google Scholar
• Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/10.1021/acs.jctc.5b00255
   PubMed Web of Science ®Google Scholar
• Miller, B. R., McGee, T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Morel, F., Rauch, C., Petit, E., Piton, A., Theret, N., Coles, B., & Guillouzo, A. (2004). Gene and protein characterization of the human glutathione S-transferase Kappa and evidence for a peroxisomal localization. The Journal of Biological Chemistry, 279(16), 16246–16253. https://doi.org/10.1074/jbc.M313357200
   PubMed Web of Science ®Google Scholar
• Morra, G., & Colombo, G. (2008). Relationship between energy distribution and fold stability: Insights from molecular dynamics simulations of native and mutant proteins. Proteins, 72(2), 660–672. https://doi.org/10.1002/prot.21963
   PubMed Web of Science ®Google Scholar
• Morra, G., Meli, M., & Colombo, G. (2018). How the ligand-induced reorganization of protein internal energies is coupled to conformational events. Journal of Chemical Theory and Computation, 14(11), 5992–6001. https://doi.org/10.1021/acs.jctc.8b00195
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Nakayama, M., Gonzalgo, M. L., Yegnasubramanian, S., Lin, X. H., De Marzo, A. M., & Nelson, W. G. (2004). GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. Journal of Cellular Biochemistry, 91(3), 540–552. https://doi.org/10.1002/jcb.10740
   PubMed Web of Science ®Google Scholar
• Oakley, A. J., Rossjohn, J., Lo Bello, M., Caccuri, A. M., Federici, G., & Parker, M. W. (1997). The three-dimensional structure of the human Pi class glutathione transferase P1-1 in complex with the inhibitor ethacrynic acid and its glutathione. Biochemistry, 36(3), 576–585. https://doi.org/10.1021/bi962316i
   PubMed Web of Science ®Google Scholar
• O'Dwyer, P. J., LaCreta, F., Nash, S., Tinsley, P. W., Schilder, R., Clapper, M. L., Tew, K. D., Panting, L., Litwin, S., & Comis, R. L. (1991). Phase-I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic-acid. Cancer Research, 51(22), 6059–6065.
   PubMed Web of Science ®Google Scholar
• Olsson, M. H. M., Søndergaard, C. R., Rostkowski, M., & Jensen, J. H. (2011). PROPKA3: Consistent treatment of internal and surface residues in empirical pK(a) predictions. Journal of Chemical Theory and Computation, 7(2), 525–537. https://doi.org/10.1021/ct100578z
   PubMed Web of Science ®Google Scholar
• Punganuru, S. R., Mostofa, A. G. M., Madala, H. R., Basak, D., & Srivenugopal, K. S. (2016). Potent anti-proliferative actions of a non-diuretic glucosamine derivative of ethacrynic acid. Bioorganic & Medicinal Chemistry Letters, 26(12), 2829–2833. https://doi.org/10.1016/j.bmcl.2016.04.062
   PubMed Web of Science ®Google Scholar
• Rocha, D., Gut, I., Jeffreys, A. J., Kwok, P. Y., Brookes, A. J., & Chanock, S. J. (2006). Seventh international meeting on single nucleotide polymorphism and complex genome analysis: 'ever bigger scans and an increasingly variable genome. Human Genetics, 119(4), 451–456. https://doi.org/10.1007/s00439-006-0151-z
   PubMed Web of Science ®Google Scholar
• Sachidanandam, R., Weissman, D., Schmidt, S. C., Kakol, J. M., Stein, L. D., Marth, G., Sherry, S., Mullikin, J. C., Mortimore, B. J., Willey, D. L., Hunt, S. E., Cole, C. G., Coggill, P. C., Rice, C. M., Ning, Z., Rogers, J., Bentley, D. R., Kwok, P. Y., Mardis, E. R., … Altshuler, D. (2001). A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature, 409(6822), 928–933. https://doi.org/10.1038/35057149
   PubMed Web of Science ®Google Scholar
• Sawers, L., Ferguson, M. J., Ihrig, B. R., Young, H. C., Chakravarty, P., Wolf, C. R., & Smith, G. (2014). Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines. British Journal of Cancer, 111(6), 1150–1158. https://doi.org/10.1038/bjc.2014.386
   PubMed Web of Science ®Google Scholar
• Singh, S., Okamura, T., & Ali-Osman, F. (2010). Serine phosphorylation of glutathione S-transferase P1 (GSTP1) by PKC alpha enhances GSTP1-dependent cisplatin metabolism and resistance in human glioma cells. Biochemical Pharmacology, 80(9), 1343–1355. https://doi.org/10.1016/j.bcp.2010.07.019
   PubMed Web of Science ®Google Scholar
• Sprenger, K. G., Jaeger, V. W., & Pfaendtner, J. (2015). The General AMBER Force Field (GAFF) can accurately predict thermodynamic and transport properties of many ionic liquids. The Journal of Physical Chemistry. B, 119(18), 5882–5895. https://doi.org/10.1021/acs.jpcb.5b00689
   PubMed Web of Science ®Google Scholar
• Tanaka, G., Inoue, K., Shimizu, T., Akimoto, K., & Kubota, K. (2016). Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells. Cancer Medicine, 5(9), 2544–2557. https://doi.org/10.1002/cam4.844
   PubMed Web of Science ®Google Scholar
• Tayubi, I. A., Kumar, U. S., & Doss, G. P. C. (2022). Identification of potential inhibitors, conformational dynamics, and mechanistic insights into mutant Kirsten rat sarcoma virus (G13D) driven cancers. Journal of Cellular Biochemistry, 123(9), 1467–1480. https://doi.org/10.1002/jcb.30305
   PubMed Web of Science ®Google Scholar
• Tchou, J. C., Lin, X., Freije, D., Isaacs, W. B., Brooks, J. D., Rashid, A., De Marzo, A. M., Kanai, Y., Hirohashi, S., & Nelson, W. G. (2000). GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. International Journal of Oncology, 16(4), 663–676. https://doi.org/10.3892/ijo.16.4.663
   PubMed Web of Science ®Google Scholar
• Tew, K. D., Bomber, A. M., & Hoffman, S. J. (1988). Ethacrynic-acid and piriprost as enhancers of cyto-toxicity in drug-resistant and sensitive cell-lines. Cancer Research, 48(13), 3622–3625.
   PubMed Web of Science ®Google Scholar
• Townsend, D. M., & Tew, K. D. (2003). The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene, 22(47), 7369–7375. https://doi.org/10.1038/sj.onc.1206940
   PubMed Web of Science ®Google Scholar
• Wang, R., Liu, C., Xia, L., Zhao, G., Gabrilove, J., Waxman, S., & Jing, Y. (2012). Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: The role of glutathione S-transferase P1-1. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 18(24), 6690–6701. https://doi.org/10.1158/1078-0432.CCR-12-0770
   PubMed Web of Science ®Google Scholar
• Won, M., Koo, S., Li, H., Sessler, J. L., Lee, J. Y., Sharma, A., & Kim, J. S. (2021). An ethacrynic acid-brominated BODIPY photosensitizer (EA-BPS) construct enhances the lethality of reactive oxygen species in hypoxic tumor-targeted photodynamic therapy. Angewandte Chemie (International ed. in English), 60(6), 3196–3204. https://doi.org/10.1002/anie.202012687
   PubMed Web of Science ®Google Scholar
• Zhao, G., Liu, C., Wang, R., Song, D., Wang, X., Lou, H., & Jing, Y. (2007). The synthesis of alpha,beta-unsaturated carbonyl derivatives with the ability to inhibit both glutathione S-transferase P1-1 activity and the proliferation of leukemia cells. Bioorganic & Medicinal Chemistry, 15(7), 2701–2707. https://doi.org/10.1016/j.bmc.2007.01.037
   PubMed Web of Science ®Google Scholar